C.R. Bard reports a 3rd-quarter earnings gain of nearly 50% and raises its guidance for the rest of the year, sending share prices up this morning on Wall Street.
C.R. Bard (NYSE:BCR) shares are up more than 3% this morning on Wall Street after the medical device company reported that its 3rd-quarter earnings rose 47.0% compared with the same period last year.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1tkGpu6
Cap comentari:
Publica un comentari a l'entrada